
Tirzepatide
CAS 2023788-19-2 · C225H348N48O68 · 4813.45 g/mol
Also known as: LY3298176, LY-3298176
Dual GIP/GLP-1 receptor agonist peptide studied in metabolic research, supplied as a 30 mg lyophilized vial for in-vitro and analytical work.
TT$2,000.00indicative · 30 mg
In stockPrices in TT$. Final quote confirmed after enquiry review.
Wholesale price match guarantee: show us a competitor's wholesale quote and we'll match it and beat it.
Island-wide delivery across Trinidad and Tobago is arranged after your enquiry is approved. Orders are packed in insulated packaging with cold packs and dispatched on weekdays.
RESEARCH USE ONLY
For research use only. Not for human or veterinary use. Not a drug, food, supplement or cosmetic. Not intended to diagnose, treat, cure or prevent any disease.
Tirzepatide specifications
| Product name | Tirzepatide |
|---|---|
| CAS number | 2023788-19-2 |
| Synonyms | LY3298176; LY-3298176 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.45 g/mol |
| Sequence | YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS-NH2 |
| Purity (HPLC) | Per batch COA |
| Form | Lyophilized powder |
| Vial size | 30 mg |
| Storage | Store sealed at −20 °C, desiccated and protected from light. |
| Indicative price | TT$2,000.00 |
| Last updated |
About Tirzepatide
Tirzepatide is a synthetic 39-residue peptide characterised as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Positions 2 and 13 carry α-aminoisobutyric acid (Aib, shown as X in the sequence), the C-terminus is a serine amide, and the lysine at position 20 is acylated with a C20 fatty diacid through a γ-glutamic acid and two 8-amino-3,6-dioxaoctanoic acid linker units.
In metabolic research it is studied as a reference agonist in cell-based GIP and GLP-1 receptor assays, such as cAMP accumulation and receptor binding experiments, in comparisons of single, dual and triple receptor agonists, and as an analytical standard for lipidated peptides in LC-MS method development.
The fatty diacid side chain makes tirzepatide considerably more hydrophobic than unmodified peptides of a similar length, which affects reversed-phase retention and can cause adsorption to some plastics. With a molecular weight of about 4.8 kDa, electrospray spectra show several multiply charged ions, so compare the deconvoluted mass with the theoretical value. Purity for each batch is reported on its certificate of analysis. For laboratory research use only.
Certificate of analysis
Every batch of Tirzepatide is supplied with a certificate of analysis reporting purity by HPLC, identity by mass spectrometry and the lot number printed on the vial.
The certificate for the current batch is available on request with your enquiry.
Tirzepatide FAQ
How should Tirzepatide be stored?
Store sealed at −20 °C, desiccated and protected from light. Allow the sealed vial to reach room temperature before opening so moisture does not condense on the lyophilized powder.
Is a certificate of analysis supplied with Tirzepatide?
Yes. Every batch of Tirzepatide (CAS 2023788-19-2) is supplied with a certificate of analysis reporting HPLC purity, mass spectrometry identity and the lot number.
What purity is Tirzepatide?
Purity is reported per batch: the reversed-phase HPLC figure for your lot is printed on its certificate of analysis, available on request with your enquiry.
Can Tirzepatide be delivered in Trinidad and Tobago?
Yes. Island-wide delivery across Trinidad and Tobago is arranged after your enquiry is approved. Orders are packed in insulated packaging with cold packs and dispatched on weekdays.



